Learned blood-omics factors track Rett syndrome status and severity in a small cohort
Source check: Source checked. Not independent scientific confirmation.
Finding: Unsupervised integration of four blood-omics measurements identified a disease-associated molecular factor and a second factor correlated with clinical severity in nine people with Rett syndrome and eight controls. The learned factors connect measurements across molecular layers, but remain exploratory within-cohort associations. They are not validated diagnostic tests, causal disease mechanisms or demonstrated treatment-response markers.
Technology: MOFA2 unsupervised multi-omics latent-factor learning
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- MOFA2 learned shared variation across transcript, protein, phosphorylation and metabolite measurements, enabling the represented cross-layer disease and severity-associated factor analysis beyond separate differential-expression tests.
- Test and result
- Four matched molecular-data layers from nine Rett syndrome participants and eight controls were integrated using MOFA2 latent-factor learning. The main computational Methods specify normalized inputs, participant-identifier joins and associations between factor scores and clinical severity. Factor 1 separated the sampled clinical groups; Factor 2 correlated with severity among the nine affected participants, with reported Spearman rho 0.77 and nominal p 0.016.
- Limitation / still unknown
- Seventeen people and nine severity observations are too few to establish generalizable biomarker performance. Factor selection and severity association used the same cohort, without held-out diagnostic evaluation or demonstrated multiplicity-adjusted confirmation of the severity result. Age, cell composition, medication, diet and systemic physiology may influence molecular profiles; peripheral blood does not directly establish brain mechanisms. Orthogonal measurement of an individual metabolite does not independently validate the learned latent factors. No longitudinal response-to-treatment or causal effect was tested.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13745417/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Read primary cohort/reference metadata, computational normalization/integration/MOFA2 factor and severity-association Methods, corresponding factor Results and clinical/confounding limitations. No laboratory procedures were independently adjudicated. Individual metabolite confirmation is not counted as independent latent-model validation. Exact original article front DOI/title and fresh PubMed primary relationship metadata checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.